Table 1.
Ancestral population | Non-risk vs risk allele carriers | Non-risk allele carriers: controls vs cases | ||||
---|---|---|---|---|---|---|
Dosage | Difference | P value | dosage | difference | P value | |
AFR | 0.470/0.213 | 0.257 | <1.00E−04 | 0.452/0.600 | −0.148 | 1.20E−03 |
EAS | 0.641/1.344 | −0.703 | <1.00E−04 | 0.668/0.452 | 0.216 | <1.00E−04 |
EUR | 0.889/0.443 | 0.446 | <1.00E−04 | 0.881/0.948 | −0.067 | 8.31E−02 |
AFR–EAS | −0.154/−0.726 | 0.573 | <1.00E−04 | −0.193/0.141 | −0.334 | <1.00E−04 |
AFR–EUR | −0.308/−0.351 | 0.043 | 3.40E−01 | −0.322/−0.224 | −0.098 | 5.77E−02 |
EAS–EUR | −0.162/0.504 | −0.666 | <1.00E−04 | −0.138/−0.353 | 0.216 | 9.00E−04 |
Dosage means for single ancestral populations and normed differences for two populations were compared between risk (N = 45) and non-risk allele (N = 956) carriers as well as between controls (N = 838) and neutropenia cases (N = 118) not carrying the risk allele. P values were determined by permutation tests (N = 10,000). Significant results are in bold.